Related references
Note: Only part of the references are listed.TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV
Roy Matkovic et al.
NATURE COMMUNICATIONS (2022)
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
Jocelyn T. Kim et al.
NATURE COMMUNICATIONS (2022)
Non-Canonical Roles of Apoptotic Caspases in the Nervous System
Mahshid H. Dehkordi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
T cell stimulation remodels the latently HIV-1 infected cell population by differential activation of proviral chromatin
Birgitta Lindqvist et al.
PLOS PATHOGENS (2022)
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis
Ethan M. Weinberg et al.
LIVER TRANSPLANTATION (2021)
Latency Reversal 2.0: Giving the Immune System a Seat at the Table
Vidisha Singh et al.
CURRENT HIV/AIDS REPORTS (2021)
Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
Elisa Saccon et al.
FRONTIERS IN IMMUNOLOGY (2021)
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
Guadalupe Garcia-Tsao et al.
JOURNAL OF HEPATOLOGY (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
Maria Rosa Lopez-Huertas et al.
SCIENTIFIC REPORTS (2020)
Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo
Catherine T. Frenette et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2019)
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease
Mitchell Shiffman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2019)
The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques
Mireille Laforge et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
Matthew D. Marsden et al.
VIROLOGY (2018)
Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
Wang Zhang et al.
FRONTIERS IN MICROBIOLOGY (2018)
DOCK8 Drives Src-Dependent NK Cell Effector Function
Conor J. Kearney et al.
JOURNAL OF IMMUNOLOGY (2017)
HIV integration sites in latently infected cell lines: evidence of ongoing replication
Jori Symons et al.
RETROVIROLOGY (2017)
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell kick and kill in strategy for virus eradication
Matthew D. Marsden et al.
PLOS PATHOGENS (2017)
Developmental and Functional Control of Natural Killer Cells by Cytokines
Yang Wu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Modeling Kick-Kill Strategies toward HIV Cure
Esteban A. Hernandez-Vargas
FRONTIERS IN IMMUNOLOGY (2017)
Understanding HIV Latency: The Road to an HIV Cure
Matthew S. Dahabieh et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency
Lars Pache et al.
CELL HOST & MICROBE (2015)
Can HIV Be Cured and Should We Try?
Nathan W. Cummins et al.
MAYO CLINIC PROCEEDINGS (2015)
Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication
R. van Domselaar et al.
CELL DEATH AND DIFFERENTIATION (2013)
Calcium/Calcineurin Synergizes with Prostratin to Promote NF-κB Dependent Activation of Latent HIV
Jonathan K. Chan et al.
PLOS ONE (2013)
An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+T Cells from Aviremic Patients
Celsa A. Spina et al.
PLOS PATHOGENS (2013)
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Evelyn Eisele et al.
IMMUNITY (2012)
Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors
Rutger J. Wierda et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
RIP3 mediates the embryonic lethality of caspase-8-deficient mice
William J. Kaiser et al.
NATURE (2011)
Cell death-independent functions of granzymes: hit viruses where it hurts
Robert van Domselaar et al.
REVIEWS IN MEDICAL VIROLOGY (2011)
Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C
M. L. Shiffman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Cyril Fauriat et al.
BLOOD (2010)
Noncytotoxic Inhibition of Cytomegalovirus Replication through NK Cell Protease Granzyme M-Mediated Cleavage of Viral Phosphoprotein 71
Robert van Domselaar et al.
JOURNAL OF IMMUNOLOGY (2010)
Human NK Cells Require Caspases for Activation-Induced Proliferation and Cytokine Release but not for Cytotoxicity
S. Ussat et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation
Jose F. Camargo et al.
JOURNAL OF IMMUNOLOGY (2009)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
CXCR4-CCR5: A couple modulating T cell functions
Rita Lucia Contento et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection
Kyra Oswald-Richter et al.
PLOS PATHOGENS (2007)
Suv39H1 and HP1γ are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency
Isaure du Chene et al.
EMBO JOURNAL (2007)
Functional analysis of granzyme M and its role in immunity to infection
LI Pao et al.
JOURNAL OF IMMUNOLOGY (2005)
Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity
LS Weinberger et al.
CELL (2005)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cytotoxic T lymphocytes: All roads lead to death
M Barry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP
JY Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
